5 countries prioritizing stem cell treatments

Written by Adam Schrag | April 24, 2017 | Print  |

Five countries led the way in stem cell medication clinical trials administered between 1999 and 2016, according to The National Institute of Food and Drug Safety in South Korea.

Here are the five countries leading the way in stem cell clinical trials:

 

1. The U.S. ranked first with a total of 314 clinical trials on stem cell medications registered with the NIH from 1999 to 2016.

 

2. South Korea reportedly registered 46 clinical trials spanning from 1999 to 2016.

 

3. China placed third, with 29 clinical trials administered since 1999. South Korea and China tied in 2014 by registering five clinical trials each and China overtook South Korea last year before South Korea jumped back to second in 2016.

 

4. Spain and Israel were fourth and fifth on the list, respectively.

 

More articles on practice management:
How can physicians avoid burnout? Dr. Shaina Drummond reveals key tips

Trump gives high praise to GOP healthcare draft proposal — 3 insights

This independent physician network balances physicians' needs and desires — 5 takeaways

© Copyright ASC COMMUNICATIONS 2019. Interested in LINKING to or REPRINTING this content? View our policies here.

Top 40 Articles from the Past 6 Months